Stover; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stover; David.The latest application filed is for "formulated and/or co-furmulated liposome compositions containing toll-like receptor ("tlr") agonist prodrugs useful in the treatment of cancer and methods thereof".

Company Profile

2.3.10

Stover; David - Encino CA
Stover; David - Santa Barbara CA
Stover, David - Meridian ID

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formulated and/or co-furmulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof App 20220193187 - Stover; David ; et al.	2022-06-23
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof App 20220080051 - Stover; David ; et al.	2022-03-17
Fusion Protein Composition(s) Comprising Masked Type I Interferons (ifna And Ifnb) For Use In The Treatment Of Cancer And Methods Thereof App 20220056076 - STOVER; David ; et al.	2022-02-24
Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof Grant 11,136,353 - Stover , et al. October 5, 2	2021-10-05
Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof App 20210260197 - Stover; David ; et al.	2021-08-26
Formulated and/or co-formulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof App 20210187066 - Stover; David ; et al.	2021-06-24
Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful In The Treatment of Cancer and Methods Thereof App 20210163418 - Stover; David ; et al.	2021-06-03
Fusion Protein Composition(s) Comprising Masked Type I Interferons (ifna And Ifnb) For Use In The Treatment Of Cancer And Methods Thereof App 20200331966 - STOVER; David ; et al.	2020-10-22
Fault-tolerant power network Grant 10,547,206 - Stewart , et al. Ja	2020-01-28
Fault-tolerant Power Network App 20180115191 - Stewart; Heath ; et al.	2018-04-26
High-Frequency electrostatically shielded toroidal plasma and radical source App 20040237897 - Hanawa, Hiroji ; et al.	2004-12-02
High-frequency electrostatically shielded toroidal plasma and radical source Grant 6,634,313 - Hanawa , et al. October 21, 2	2003-10-21
High-frequency electrostatically shielded toroidal plasma and radical source App 20020108713 - Hanawa, Hiroji ; et al.	2002-08-15

Company Registrations

NCAGE Code	4K6J5	STOVER, DAVID!DBA ETECH CONNECT
CAGE Code	4K6J5	STOVER, DAVID ETECH CONNECT
DUNS	005129601	STOVER, DAVID

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.